drugset / Trial / NCT00227435
Dose Escalation Study to Evaluate the Safety and Antiviral Activity of Val-mCyd in Adults With Chronic Hepatitis C
RandomizedParallel-groupDouble-blindTreatment
Summary
This study was conducted to determine the safety, tolerance, pharmacokinetics and antiviral activity of val-mCyd at doses ranging from 50 mg to 800 mg per day.
Timeline
- Start
- 2003-02
- Primary completion
- 2004-07
- Completion
- 2004-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | val-mCyd | Unknown | 50 mg | — |
| Subject | val-mCyd | Unknown | 800 mg | — |